Nicotinamide Riboside: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Nicotinamide Riboside

• Comparisons of NAD Precursors for Neuroenhancement in Glaucoma Patients
  NCT06991712 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus
  NCT06032923 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 120 Years · Sex: Female · 1 location
• Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate
  NCT06044935 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients
  NCT05732051 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
• Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
  NCT03821623 · Phase: Phase 2 · Ages: 50 Years and older · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Nicotinamide Riboside?

5 recruiting trials across 12 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.